← Open Payments lookup

MARY LYNN BRESLIN: Open Payments

NPI 1205543774 · NEPTUNE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,518 in 78 payments from 22 companies in 2025. Trend: 2023 $988 · 2024 $1,983 · 2025 $1,518

Food & beverage: $1,518
CompanyPaymentsAmount
Eisai Inc.14$213
GlaxoSmithKline, LLC.13$207
Gilead Sciences, Inc.2$142
TAIHO ONCOLOGY, INC.6$119
ABBVIE INC.5$103
Stemline Therapeutics Inc.5$93
E.R. Squibb & Sons, L.L.C.5$84
Novocure Inc.1$61
AstraZeneca Pharmaceuticals LP3$57
Pharmacosmos Therapeutics Inc.3$55

Products named: Lenvima, OJJAARA, Trodelvy, LONSURF, Orserdu, VENCLEXTA, Optune Lua (NovoTTF-200T), Enhertu.

Industry payments across NJ — which companies pay providers there.